Screener
Regenxbio RGNX Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $22.71M+132% | -$90.05M-1,580% | -$67.15M-31.2% | -$61.94M-3.9% | -$70.87M-33.7% | ||
| $3.76M-3.8% | $3.86M-2.5% | $3.87M-3.8% | $3.89M-1.9% | $3.91M-3.6% | ||
| $9.05M+4.6% | $8.62M+0.9% | $8.38M-12.2% | $9M-9.0% | $8.65M-8.3% | ||
| -$62.24M-26.1% | -$76.19M-327% | -$52.29M-65.3% | -$55.96M-38.0% | -$49.34M-8.5% | ||
| $760K+94.4% | $1.24M+20.6% | $508K-52.9% | $491K+50.6% | $391K-17.5% | ||
| $65.93M+147% | $70.59M+57.8% | —— | —— | -$140.44M— | ||
| $17.57M-87.4% | -$13.64M-135% | —— | —— | $139.23M— | ||
| $21.26M— | -$19.24M-127% | -$24.34M-2,777% | —— | —— | ||
| -$63M-26.7% | -$77.42M-337% | -$52.8M-61.4% | -$56.45M-38.1% | -$49.73M-8.2% |
FAQ
- How much cash does Regenxbio generate?
- Regenxbio (RGNX) generated -$246.7M in operating cash flow over the trailing twelve months.
- What is Regenxbio's free cash flow?
- After $3.0M of capital expenditures, Regenxbio's free cash flow was -$249.7M over the trailing twelve months, down 175.3% year over year.
- Where does Regenxbio's cash flow data come from?
- Every line is extracted from Regenxbio's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
